GE Infant Warmer Recalled Due to Oxygen Mixer Problems

A recall has been issued for resuscitation systems installed in infant warmers, due to a possible manufacturing error that may reverse the oxygen mixing concentrations, posing a risk of serious and potentially life-threatening injuries for infants receiving the treatment.

GE Healthcare notified consumers in October 2012 about potential problems’s with the company’s resuscitation systems with blenders, which are installed in GE Giraffe and Panda infant warmers. However, the FDA determined last week that the action constitutes a Class I medical device recall, suggesting that continued use of the resuscitation systems carries a reasonable probability of serious adverse health consequences or death.

The oxygen and air inlet fittings and labels located on the back panel of the device may have been reversed during assembly, which could cause the air and oxygen concentrations to potentially reverse. As a result, the setting of the blender knob may not inaccurately reflect the amount of oxygen produced.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall consists of field upgrade kits for GE Healthcare’s resuscitation systems with blender, installed in GE Giraffe and Panda infant warmers manufactured between April 2008 and September 2012.

GE Healthcare began notifying customers with affected units by sending an “Urgent Medical Device” letter in October, consisting of instructions and illustrations to allow hospital personnel to inspect and correct the device immediately and how to confirm their receipt of the letter.

Consumers with affected products should stop using the product immediately and contact GE Healthcare Customer Service at 1-800-345-2700 to schedule an inspection and mitigation.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted today)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted today)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 3 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.